| Aging Oligodendrocytes | |
|---|---|
| Lineage | Glia > Oligodendrocyte > Aging |
| Markers | OLIG2, MBP, PLP1, MAG, MOG |
| Brain Regions | White Matter, Subcortical Regions, Corpus Callosum |
| Disease Vulnerability | Alzheimer's Disease, Parkinson's Disease, White Matter Lesions, Vascular Dementia |
Aging oligodendrocytes are mature myelin-producing cells that undergo functional and structural changes during the normal aging process. Oligodendrocytes are responsible for forming and maintaining the myelin sheath that insulates axons in the central nervous system, enabling rapid saltatory conduction of nerve impulses[1]. With aging, oligodendrocytes exhibit reduced metabolic activity, altered gene expression, and compromised myelin maintenance, contributing to white matter degeneration and cognitive decline.
Aging Oligodendrocytes are a specialized cell type classified within the Glia > Oligodendrocyte > Aging lineage[1:1]. These cells are primarily found in White Matter, Subcortical Regions, and the Corpus Callosum. They are characterized by expression of marker genes including OLIG2, MBP, PLP1, MAG, and MOG. They are selectively vulnerable or involved in Alzheimer's Disease, Parkinson's Disease, White Matter Lesions, and Vascular Dementia.
Aging oligodendrocytes can be identified by the expression of key marker genes:
Oligodendrocytes continue to maintain and remodel myelin throughout life[2]:
White matter integrity is essential for efficient neural communication:
Aging oligodendrocytes undergo morphological alterations[3]:
Aging affects oligodendrocyte function:
Gene expression changes in aging oligodendrocytes[4]:
Aging oligodendrocytes contribute to AD pathology[5]:
In PD, aging oligodendrocytes show:
Aging oligodendrocytes are central to white matter lesions:
Oligodendrocyte vulnerability in vascular dementia:
Promoting oligodendrocyte regeneration[6]:
Protecting aging oligodendrocytes:
The study of Aging Oligodendrocytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Simons & Nave, Oligodendrocytes: Myelination and axonal support (2015) ↩︎ ↩︎
Nave & Trapp, Axon-glial signaling and the glial support of axon function (2008) ↩︎
Peters, The effects of normal aging on myelin and nerve fibers (2009) ↩︎
Lu et al., Transcriptomic analysis of aging oligodendrocytes (2020) ↩︎
Miller & Borst, White matter pathology in Alzheimer's disease (2019) ↩︎
Franklin & ffrench-Constant, Remyelination in the CNS (2008) ↩︎